Author/Authors :
zoofaghari, shafeajafar isfahan university of medical sciences - isfahan clinical toxicology research center, - department of clinical toxicology, isfahan, iran , fazeli dehkordi, afshar isfahan university of medical sciences - isfahan clinical toxicology research center - department of clinical toxicology, isfahan, iran , nemati, kourosh isfahan university of medical sciences - isfahan clinical toxicology research center - department of clinical toxicology, isfahan, iran , hashemzadeh, mozhdeh isfahan university of medical sciences - school of management and medical informat - department of medical library and information science, clinical informationist research group, isfahan, iran , otroshi, arman isfahan university of medical sciences - isfahan clinical toxicology research center - department of clinical toxicology, isfahan, iran
Abstract :
organophosphate (op) poisoning is prevalent in developing countries. toxicity occurs by voluntary injection, inhalation, and absorption. self-injection is rare. the current case report describes a 61-y/o male with subcutaneous self-injected one cc op poisoning presenting with delayed drowsiness, nausea, and vomiting. he was treated and presented a good clinical response to treatment with pralidoxime and had a successful recovery. diagnosis of op compound toxicity by the parenteral route is a challenge. by observing patients, the dose, and the time between poisoning until the time to start treatment, we can conclude different presentations and outcomes of op poisoning.
Keywords :
organophosphate poisoning , diazinon , injections , subcutaneous , case report
